- Home
- GENC vs AVR Comparison
GENC vs AVR Comparison
Compare GENC & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- AVR
- Stock Information
- Founded
- GENC 1894
- AVR 1999
- Country
- GENC United States
- AVR Australia
- Employees
- GENC N/A
- AVR N/A
- Industry
- GENC Construction/Ag Equipment/Trucks
- AVR
- Sector
- GENC Industrials
- AVR
- Exchange
- GENC Nasdaq
- AVR NYSE
- Market Cap
- GENC 204.9M
- AVR 241.5M
- IPO Year
- GENC N/A
- AVR 2024
- Fundamental
- Price
- GENC $13.79
- AVR $4.24
- Analyst Decision
- GENC
- AVR Strong Buy
- Analyst Count
- GENC 0
- AVR 4
- Target Price
- GENC N/A
- AVR $16.50
- AVG Volume (30 Days)
- GENC 19.9K
- AVR 148.4K
- Earning Date
- GENC 06-13-2025
- AVR 05-13-2025
- Dividend Yield
- GENC N/A
- AVR N/A
- EPS Growth
- GENC 35.02
- AVR N/A
- EPS
- GENC 1.11
- AVR N/A
- Revenue
- GENC $113,116,000.00
- AVR $2,493,000.00
- Revenue This Year
- GENC N/A
- AVR $29.52
- Revenue Next Year
- GENC N/A
- AVR $204.83
- P/E Ratio
- GENC $12.48
- AVR N/A
- Revenue Growth
- GENC 5.44
- AVR N/A
- 52 Week Low
- GENC $10.80
- AVR $2.34
- 52 Week High
- GENC $24.88
- AVR $8.79
- Technical
- Relative Strength Index (RSI)
- GENC 56.24
- AVR N/A
- Support Level
- GENC $13.40
- AVR N/A
- Resistance Level
- GENC $14.49
- AVR N/A
- Average True Range (ATR)
- GENC 0.62
- AVR 0.00
- MACD
- GENC 0.02
- AVR 0.00
- Stochastic Oscillator
- GENC 53.02
- AVR 0.00
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.